Galecto Biotech (private company)

Galecto Biotech AB develops galectin modulators for the treatment of severe diseases, including fibrosis, cancer and inflammation

Companies with similar profile to Galecto Biotech:

Company	Criteria
STipe Therapeutics 76%	Similar verticals: Biotech, Health services Similar business models: B2B At least one vc investor: Sunstone Life Science Ventures At least one other investor: Novo A/S Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
AFYX Therapeutics 66%	Similar verticals: Biotech, Health services Similar business models: B2B At least one vc investor: Novo Seeds Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
NMD Pharma 66%	Similar verticals: Biotech, Health services Similar business models: B2B At least one vc investor: Novo Seeds Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Tubulis 66%	Similar verticals: Biotech, Health services Similar business models: B2B At least one vc investor: Seventure Partners Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Oncoinvent 66%	Similar verticals: Biotech, Health services Similar business models: B2B At least one vc investor: Hadean Ventures At least one other investor: Canica AS Total raised in a similar range: 10M+ USD
Draupnir Bio 66%	Similar verticals: Biotech, Health services Similar business models: B2B At least one vc investor: Novo Seeds Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Orphazyme 65%	Similar verticals: Biotech Similar business models: B2B At least one vc investor: Sunstone Life Science Ventures At least one other investor: Novo A/S Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Forendo Pharma 65%	Similar verticals: Health services Similar business models: B2B At least one vc investor: Sunstone Life Science Ventures, Novo Seeds At least one other investor: Merck Ventures Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Sanifit Therapeutics 64%	Similar verticals: Biotech, Health services Similar business models: B2B At least one other investor: Ysios Capital Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
ReViral 64%	Similar verticals: Biotech, Health services Similar business models: B2B At least one other investor: Novo A/S, OrbiMed Advisors Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
MinervaX 56%	Similar verticals: Biotech, Health services Similar business models: B2B At least one vc investor: Seed Capital, Sunstone Life Science Ventures, Novo Seeds Total raised in a similar range: 10M+ USD
Antag Therapeutics 56%	Similar verticals: Biotech, Health services Similar business models: B2B At least one vc investor: Novo Seeds Minim one investor from outside Scandinavia: Yes
CardioMech 55%	Similar verticals: Health services Similar business models: B2B At least one vc investor: Hadean Ventures Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Acarix 55%	Similar verticals: Health services Similar business models: B2B At least one vc investor: Seed Capital, Sunstone Life Science Ventures, Seventure Partners Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Gesynta Pharma 55%	Similar verticals: Health services Similar business models: B2B At least one vc investor: Hadean Ventures At least one other investor: Novo A/S Total raised in a similar range: 10M+ USD
Reapplix 55%	Similar verticals: Biotech Similar business models: B2B At least one vc investor: Seed Capital, Novo Seeds Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
OxThera 55%	Similar verticals: Biotech Similar business models: B2B At least one vc investor: Sunstone Life Science Ventures Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
AMRA 55%	Similar verticals: Health services Similar business models: B2B At least one vc investor: Novo Seeds Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
IO Biotech 55%	Similar verticals: Biotech Similar business models: B2B At least one vc investor: Sunstone Life Science Ventures At least one other investor: Novo A/S Total raised in a similar range: 10M+ USD
Alvotech 54%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes